Given that MSCs from patients with MN are characterized by aneuploidy and are functionally impaired, we evaluated the role of the FOXM1 gene in MSCs isolated from patients with de novo and therapy-related MDS and AML. Here, FOXM1 is linked to myelodysplastic syndrome.